Immunic to participate in industry and scientific conferences in june

New york , may 28, 2024 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in june: june 3-6: bio international convention 2024. jessica breu, vice president investor relations and communications of immunic, will present a company overview on tuesday, june 4, 2024, at 11:00 am pdt in theater 1, at this conference in san diego, california.
IMUX Ratings Summary
IMUX Quant Ranking